Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33216636.
- Also identified by DOI 10.7326/M20-7357 and PMC identifier 7713906.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This commentary discusses the early licensing and deployment of a COVID-19 vaccine and how accomplishing this goal could compromise ethical principles that guide clinical research.
Medical subject headings
- COVID-19
- COVID-19 Vaccines
- Drug Industry
- Ethics, Research
- Randomized Controlled Trials as Topic